share_log

Cormedix Q3 2024 GAAP EPS $(0.05) Beats $(0.14) Estimate, Sales $11.456M Beat $10.839M Estimate

Cormedix Q3 2024 GAAP EPS $(0.05) Beats $(0.14) Estimate, Sales $11.456M Beat $10.839M Estimate

cormedix 2024年第三季度的每股收益为$(0.05),超过了$(0.14)的预估,销售额为1145.6万,超过了1083.9万的预估
Benzinga ·  2024/10/30 19:33

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.14) by 64.29 percent. The company reported quarterly sales of $11.456 million which beat the analyst consensus estimate of $10.839 million.

Cormedix(纳斯达克:CRMD)报告每股亏损$(0.05),超过分析师预估的$(0.14),增长64.29%。该公司报告季度销售额为$1145.6万,超过分析师预估的$1083.9万。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发